How to Get Jatenzo in New Hampshire

What Jatenzo Is and Why It Matters for NH Patients

Jatenzo is the brand name for oral testosterone undecanoate, the first FDA-approved oral testosterone capsule for men with hypogonadism. The FDA approved it in March 2019 based on a key trial by Swerdloff et al. (2020) that enrolled 166 hypogonadal men and showed 87% of subjects achieved average serum testosterone concentrations within the normal range (222 to 800 ng/dL) at the end of the 12-month titration period.

For men in New Hampshire, Jatenzo removes the need for intramuscular injections or topical gels that carry transfer risk. The oral capsule is taken twice daily with food, a dosing schedule that fits easily into daily routines. Because the drug uses a self-emulsifying formulation absorbed through the lymphatic system rather than first-pass hepatic metabolism, it avoids the liver toxicity concerns historically associated with older oral androgens like methyltestosterone.

New Hampshire's regulatory environment is straightforward for testosterone prescribing. The state Board of Medicine allows telehealth-initiated controlled substance prescriptions when a valid patient-provider relationship has been established, and the NH Board of Pharmacy permits 503A compounding pharmacies to operate and ship within the state. These two facts open multiple pathways to access.

Step-by-Step: Getting a Jatenzo Prescription in New Hampshire

The process starts with confirming a diagnosis of male hypogonadism. You need two separate morning serum testosterone levels below 300 ng/dL, drawn between 7:00 and 10:00 AM, on two different days. This is the threshold the Endocrine Society's 2018 clinical practice guideline uses to define testosterone deficiency in men.

Here is the sequence most NH patients follow:

1. Schedule a visit (telehealth or in-person) with a licensed prescriber in New Hampshire.
2. Complete bloodwork: total testosterone (two morning draws), free testosterone, LH, FSH, CBC, comprehensive metabolic panel, lipid panel, and PSA if you are over 40.
3. Review results with your provider. If both testosterone levels fall below 300 ng/dL and symptoms align, you meet the diagnostic criteria.
4. Your prescriber writes the Jatenzo prescription, specifying the starting dose of 237 mg twice daily with food.
5. The prescription is sent to a pharmacy that stocks Jatenzo or a 503A compounding pharmacy that dispenses oral testosterone undecanoate.
6. If your insurer requires prior authorization, your provider's office submits clinical documentation (lab values, symptom history, prior treatment failures if applicable).
7. You pick up or receive your medication by mail.

The entire process, from first lab draw to medication in hand, typically takes 5 to 14 business days. PA delays are the most common bottleneck.

Telehealth Access in New Hampshire

New Hampshire permits telehealth prescribing for Jatenzo. That is the short answer. The state adopted permanent telehealth parity legislation (NH RSA 415-J) that requires insurers to cover telehealth services at the same rate as in-person visits, and the NH Board of Medicine allows prescribers to establish a patient-provider relationship via synchronous audio-video consultation.

Several telehealth platforms serve NH residents for testosterone replacement therapy. When evaluating a telehealth provider, confirm three things: that the prescriber holds an active New Hampshire medical license (or operates under the Interstate Medical Licensure Compact, which NH has joined), that the platform orders lab work through a CLIA-certified lab accessible in NH, and that the pharmacy they use can ship to your NH address.

Telehealth visits for testosterone therapy in New Hampshire typically last 15 to 30 minutes. The prescriber will review your labs, ask about symptoms (fatigue, reduced libido, decreased muscle mass, mood changes), and assess contraindications. Men with hematocrit above 54%, untreated severe obstructive sleep apnea, or a recent cardiovascular event within the past 6 months are not candidates for testosterone therapy per Endocrine Society guidelines.

One practical advantage of telehealth for NH patients: New Hampshire is a relatively rural state with limited endocrinology access. The NH Department of Health and Human Services has designated several regions as Health Professional Shortage Areas, making in-person specialist visits difficult for men outside Manchester, Nashua, or Concord. Telehealth closes that gap.

Who Can Prescribe Jatenzo in New Hampshire

New Hampshire law allows MDs, DOs, nurse practitioners (APRNs with prescriptive authority), and physician assistants to prescribe Schedule III controlled substances, which includes testosterone. The prescriber must hold an active DEA registration and a valid NH license.

APRNs in New Hampshire gained full practice authority under NH RSA 326-B, meaning they can prescribe Jatenzo independently without a collaborative physician agreement. This expands the pool of available prescribers significantly, especially in rural parts of the state. PAs prescribe under their supervising physician's DEA number in most cases, though NH has moved toward more autonomous PA practice in recent years.

For a straightforward hypogonadism case with clear lab findings, a primary care provider can prescribe Jatenzo without referring to endocrinology. Referral to a specialist becomes appropriate when the cause of hypogonadism is unclear, when pituitary pathology is suspected (very low LH with very low testosterone), or when the patient is under 30.

Pharmacy and 503A Compounding Options in New Hampshire

Jatenzo as the brand-name product is available at retail pharmacies that stock it. Not every pharmacy carries it. CVS, Walgreens, and independent pharmacies in NH can order it, but availability varies by location. Specialty pharmacies tend to be more reliable for stocking Jatenzo because it is a higher-cost branded medication.

The alternative pathway is 503A compounding. New Hampshire licenses 503A compounding pharmacies that can prepare oral testosterone undecanoate capsules based on a valid patient-specific prescription. These pharmacies operate under FDA Section 503A of the Federal Food, Drug, and Cosmetic Act and must compound in response to individual prescriptions rather than in bulk. The cost of compounded oral testosterone undecanoate is typically 60% to 80% lower than brand-name Jatenzo, which lists at approximately $650 to $900 per month without insurance.

Mail-order pharmacy is another option. Several nationwide specialty pharmacies ship Jatenzo to New Hampshire addresses. Confirm that the pharmacy is licensed in NH before placing an order. The NH Board of Pharmacy maintains a list of licensed non-resident pharmacies.

Insurance, Prior Authorization, and Cost in New Hampshire

Most commercial insurers in New Hampshire will cover Jatenzo with prior authorization. PA requirements vary by plan but generally include documentation of two morning testosterone levels below 300 ng/dL, signs and symptoms consistent with hypogonadism, and sometimes evidence of prior treatment failure with a topical or injectable formulation.

NH Medicaid does not cover Jatenzo. This is a significant barrier for Medicaid-enrolled men in the state. Men on NH Medicaid who need testosterone replacement are typically limited to generic injectable testosterone cypionate, which costs $30 to $80 per month out of pocket and is covered by most Medicaid formularies.

For commercial insurance, the PA process usually takes 3 to 7 business days. Some insurers use step therapy, requiring that you try and fail a generic testosterone (injection or gel) before approving Jatenzo. If your PA is denied, your provider can file a peer-to-peer review or an appeal. According to the Endocrine Society's 2018 guideline, patient preference for oral administration is a valid clinical consideration, though insurers do not always recognize it as sufficient for step therapy override.

Self-pay patients in New Hampshire can expect to pay $650 to $900 per month for brand Jatenzo. The manufacturer, Tolmar, offers a copay assistance card that may reduce out-of-pocket costs to as low as $75 per month for commercially insured patients. Compounded oral testosterone undecanoate from a 503A pharmacy typically costs $100 to $250 per month.

Lab Requirements Before and During Jatenzo Treatment

Labs are non-negotiable before starting Jatenzo. The minimum pre-treatment panel includes total testosterone (two fasting morning draws), free testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), complete blood count (CBC), comprehensive metabolic panel, fasting lipid panel, and PSA for men over 40.

Why each lab matters: the two testosterone values confirm hypogonadism. LH and FSH distinguish primary (testicular) from secondary (pituitary) hypogonadism. CBC establishes baseline hematocrit, because testosterone can raise red blood cell production and push hematocrit above the safety threshold of 54%. The lipid panel matters because the Swerdloff et al. trial observed dose-dependent decreases in HDL cholesterol with oral testosterone undecanoate, a finding that requires monitoring.

After starting Jatenzo, the FDA-approved prescribing information recommends checking a serum testosterone trough level (drawn immediately before the morning dose) approximately 1 month after initiation or dose adjustment. The target trough is 200 to 500 ng/dL. If the trough falls outside this range, the dose is adjusted: down to 158 mg twice daily if the trough exceeds 500 ng/dL, or up to 396 mg twice daily if the trough remains below 200 ng/dL.

Ongoing monitoring every 6 to 12 months should include testosterone, CBC (watching hematocrit), lipid panel, hepatic function tests, and PSA. The Endocrine Society recommends a digital rectal examination at baseline and during follow-up in men over 40, though practice patterns vary.

Jatenzo Dosing, Administration, and Clinical Considerations

Jatenzo must be taken with food. This is not optional. The drug's lymphatic absorption pathway depends on dietary fat. In the key trial, subjects took capsules with meals containing at least 15 to 20 grams of fat. Taking Jatenzo on an empty stomach reduces bioavailability by approximately 40%, which can result in subtherapeutic testosterone levels.

The starting dose is 237 mg twice daily. Capsules should be swallowed whole. The three available dose strengths (158 mg, 198 mg, 237 mg capsules) allow titration to 158 mg, 237 mg, or 396 mg twice daily. Dose adjustments are based on trough testosterone levels drawn at steady state, approximately 4 weeks after initiation or any change.

Cardiovascular monitoring is especially relevant. The FDA added a boxed warning to all testosterone products in 2015 regarding potential cardiovascular risk. The TRAVERSE trial (N=5,204), published in the New England Journal of Medicine in 2023, found that testosterone replacement therapy did not significantly increase the incidence of major adverse cardiovascular events compared with placebo in men aged 45 to 80 with hypogonadism and pre-existing or high risk for cardiovascular disease. The hazard ratio was 0.96 (95% CI, 0.78 to 1.17). This data has shifted clinical confidence, though the FDA boxed warning remains in effect.

Blood pressure monitoring is also warranted. In the Jatenzo clinical program, increases in systolic blood pressure of 3 to 5 mmHg were observed. Men with pre-existing hypertension should have their blood pressure checked at each follow-up visit.

Transferring a Jatenzo Prescription to New Hampshire

If you are relocating to New Hampshire with an existing Jatenzo prescription from another state, the process is straightforward. Your current prescriber can transfer the prescription to an NH-licensed pharmacy. If your prescriber is not licensed in NH, you will need to establish care with a new provider in the state, which can be done via telehealth.

Most pharmacy chains (CVS, Walgreens, Rite Aid) can process interstate prescription transfers for Schedule III controlled substances. NH does not impose additional restrictions beyond federal DEA requirements for testosterone transfers. Bring your most recent lab work and a copy of your medical records to your new provider. This avoids redundant blood draws and speeds the transition.

For patients using a 503A compounding pharmacy in another state, the compounded prescription cannot simply be "transferred." Your new NH provider will need to write a new prescription directed to an NH-licensed 503A pharmacy or a compounding pharmacy licensed to ship into NH.